Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
National Heart, Lung, and Blood Institute (U.S.) | 12 | 2009 | 325 | 2.880 |
Why?
|
National Institutes of Health (U.S.) | 19 | 2010 | 791 | 2.690 |
Why?
|
Gene Transfer Techniques | 37 | 2002 | 1216 | 1.830 |
Why?
|
Muscle, Smooth, Vascular | 31 | 2014 | 1497 | 1.700 |
Why?
|
Research Support as Topic | 10 | 2010 | 696 | 1.390 |
Why?
|
Biomedical Research | 18 | 2014 | 3457 | 1.170 |
Why?
|
Coronary Disease | 29 | 2015 | 5923 | 1.040 |
Why?
|
Arteries | 18 | 2002 | 1124 | 0.970 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p27 | 12 | 2010 | 314 | 0.960 |
Why?
|
Cyclin-Dependent Kinases | 11 | 2004 | 660 | 0.950 |
Why?
|
Budgets | 5 | 2009 | 232 | 0.920 |
Why?
|
Progeria | 9 | 2012 | 182 | 0.900 |
Why?
|
Cell Cycle Proteins | 13 | 2005 | 3430 | 0.790 |
Why?
|
Coronary Restenosis | 5 | 2011 | 396 | 0.780 |
Why?
|
Cell Cycle | 11 | 2007 | 2919 | 0.760 |
Why?
|
Endothelium, Vascular | 26 | 2007 | 4422 | 0.730 |
Why?
|
Transfection | 29 | 2005 | 5742 | 0.720 |
Why?
|
Arteriosclerosis | 11 | 2001 | 1063 | 0.640 |
Why?
|
Vascular Diseases | 11 | 2011 | 1164 | 0.620 |
Why?
|
Peer Review, Research | 4 | 2009 | 341 | 0.610 |
Why?
|
Protein-Arginine N-Methyltransferases | 3 | 2011 | 127 | 0.600 |
Why?
|
Cardiovascular Diseases | 21 | 2012 | 15645 | 0.580 |
Why?
|
Genetic Vectors | 33 | 2002 | 3404 | 0.570 |
Why?
|
Intracellular Signaling Peptides and Proteins | 6 | 2012 | 2879 | 0.510 |
Why?
|
Tumor Suppressor Proteins | 8 | 2004 | 2794 | 0.490 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p21 | 7 | 2010 | 372 | 0.470 |
Why?
|
Adenoviridae | 18 | 2003 | 1092 | 0.470 |
Why?
|
Thymidine Kinase | 7 | 2001 | 286 | 0.460 |
Why?
|
Aging, Premature | 2 | 2012 | 44 | 0.450 |
Why?
|
Genomics | 7 | 2011 | 5926 | 0.440 |
Why?
|
Protein Precursors | 5 | 2012 | 1133 | 0.440 |
Why?
|
Cyclins | 9 | 2004 | 598 | 0.420 |
Why?
|
Methyltransferases | 3 | 2011 | 373 | 0.410 |
Why?
|
Research | 6 | 2009 | 1974 | 0.410 |
Why?
|
Medroxyprogesterone Acetate | 1 | 2013 | 153 | 0.410 |
Why?
|
Hormone Replacement Therapy | 2 | 2013 | 752 | 0.410 |
Why?
|
Cardiovascular System | 2 | 2012 | 840 | 0.410 |
Why?
|
Cell Division | 20 | 2004 | 4471 | 0.410 |
Why?
|
Vasoconstriction | 9 | 2001 | 594 | 0.400 |
Why?
|
Stents | 6 | 2011 | 3235 | 0.400 |
Why?
|
Organizational Objectives | 4 | 2009 | 426 | 0.400 |
Why?
|
Research Personnel | 5 | 2009 | 590 | 0.390 |
Why?
|
Estrogens, Conjugated (USP) | 1 | 2013 | 274 | 0.390 |
Why?
|
Growth Substances | 5 | 2005 | 758 | 0.390 |
Why?
|
Awards and Prizes | 2 | 2014 | 364 | 0.380 |
Why?
|
Cell Movement | 5 | 2016 | 5190 | 0.370 |
Why?
|
Myocytes, Smooth Muscle | 3 | 2014 | 701 | 0.360 |
Why?
|
Swine | 29 | 2005 | 5986 | 0.360 |
Why?
|
Financing, Organized | 2 | 2009 | 201 | 0.350 |
Why?
|
Tunica Media | 2 | 2008 | 107 | 0.350 |
Why?
|
United States | 35 | 2014 | 72896 | 0.350 |
Why?
|
Animals | 101 | 2016 | 168730 | 0.330 |
Why?
|
Cardiovascular Physiological Phenomena | 3 | 2003 | 239 | 0.330 |
Why?
|
Academic Medical Centers | 2 | 2013 | 2780 | 0.320 |
Why?
|
Gene Expression Regulation, Enzymologic | 5 | 2014 | 1166 | 0.320 |
Why?
|
DNA, Recombinant | 7 | 1998 | 455 | 0.320 |
Why?
|
Liposomes | 12 | 1997 | 787 | 0.310 |
Why?
|
Neuropilin-1 | 1 | 2009 | 90 | 0.310 |
Why?
|
Neovascularization, Physiologic | 2 | 2009 | 1376 | 0.310 |
Why?
|
Stathmin | 1 | 2008 | 68 | 0.310 |
Why?
|
Heme Oxygenase-1 | 4 | 2007 | 364 | 0.310 |
Why?
|
Genetic Privacy | 1 | 2008 | 58 | 0.300 |
Why?
|
Microtubule-Associated Proteins | 5 | 2001 | 1065 | 0.290 |
Why?
|
Angioplasty, Balloon, Coronary | 3 | 2011 | 1727 | 0.290 |
Why?
|
Werner Syndrome | 1 | 2007 | 12 | 0.290 |
Why?
|
Prodrugs | 2 | 2001 | 274 | 0.290 |
Why?
|
GA-Binding Protein Transcription Factor | 1 | 2007 | 43 | 0.290 |
Why?
|
Gene Expression | 21 | 2002 | 7581 | 0.290 |
Why?
|
Plasmids | 12 | 2006 | 2273 | 0.280 |
Why?
|
Hematologic Diseases | 3 | 2007 | 500 | 0.280 |
Why?
|
Clinical Trials as Topic | 9 | 2007 | 8039 | 0.280 |
Why?
|
Clinical Trials Data Monitoring Committees | 1 | 2007 | 25 | 0.280 |
Why?
|
Carbon Monoxide | 2 | 2007 | 560 | 0.280 |
Why?
|
Schools, Medical | 1 | 2013 | 877 | 0.270 |
Why?
|
Academies and Institutes | 1 | 2009 | 326 | 0.270 |
Why?
|
Humans | 164 | 2018 | 765823 | 0.270 |
Why?
|
Antigens, CD34 | 1 | 2009 | 657 | 0.270 |
Why?
|
Mixed Function Oxygenases | 1 | 2008 | 265 | 0.270 |
Why?
|
Estrogens | 1 | 2013 | 1527 | 0.270 |
Why?
|
STAT3 Transcription Factor | 1 | 2010 | 871 | 0.260 |
Why?
|
International Normalized Ratio | 1 | 2008 | 381 | 0.260 |
Why?
|
Apolipoproteins E | 2 | 2010 | 1458 | 0.250 |
Why?
|
Angina Pectoris | 10 | 2012 | 957 | 0.250 |
Why?
|
Catheterization | 5 | 1997 | 1434 | 0.250 |
Why?
|
Government Regulation | 1 | 2010 | 525 | 0.250 |
Why?
|
Cell Nucleus | 4 | 2011 | 2864 | 0.250 |
Why?
|
E2F Transcription Factors | 1 | 2006 | 269 | 0.250 |
Why?
|
Cytochrome P-450 Enzyme System | 1 | 2008 | 423 | 0.250 |
Why?
|
Interferon-beta | 2 | 1997 | 346 | 0.250 |
Why?
|
Access to Information | 1 | 2008 | 317 | 0.240 |
Why?
|
HLA-B7 Antigen | 8 | 1996 | 48 | 0.240 |
Why?
|
Ethics Committees, Research | 1 | 2006 | 196 | 0.240 |
Why?
|
Platelet-Derived Growth Factor | 4 | 1995 | 614 | 0.240 |
Why?
|
History, 21st Century | 4 | 2014 | 1573 | 0.240 |
Why?
|
Muscle Proteins | 3 | 2014 | 1160 | 0.240 |
Why?
|
Heme Oxygenase (Decyclizing) | 2 | 2005 | 165 | 0.240 |
Why?
|
Cells, Cultured | 21 | 2014 | 18970 | 0.230 |
Why?
|
Leptin | 2 | 2010 | 1597 | 0.230 |
Why?
|
Proto-Oncogene Proteins | 6 | 2014 | 4521 | 0.230 |
Why?
|
Genome, Human | 3 | 2008 | 4445 | 0.230 |
Why?
|
Atherosclerosis | 5 | 2016 | 3421 | 0.230 |
Why?
|
Thiazolidinediones | 1 | 2007 | 459 | 0.220 |
Why?
|
Retinoblastoma Protein | 2 | 2006 | 666 | 0.220 |
Why?
|
Pharmacogenetics | 1 | 2008 | 682 | 0.220 |
Why?
|
Mice | 46 | 2016 | 81788 | 0.220 |
Why?
|
Lung Diseases | 4 | 2007 | 1939 | 0.220 |
Why?
|
Cytomegalovirus | 2 | 1998 | 752 | 0.220 |
Why?
|
Coronary Vessels | 12 | 2012 | 3096 | 0.210 |
Why?
|
Mice, Mutant Strains | 4 | 2011 | 1746 | 0.210 |
Why?
|
Gene Expression Regulation | 11 | 2011 | 11888 | 0.210 |
Why?
|
Career Mobility | 1 | 2005 | 259 | 0.210 |
Why?
|
CDC2-CDC28 Kinases | 2 | 2000 | 111 | 0.210 |
Why?
|
Blood | 2 | 2005 | 597 | 0.210 |
Why?
|
Promoter Regions, Genetic | 7 | 2001 | 5786 | 0.210 |
Why?
|
History, 20th Century | 4 | 2014 | 2761 | 0.210 |
Why?
|
Drug-Eluting Stents | 1 | 2009 | 683 | 0.200 |
Why?
|
Myocardial Infarction | 11 | 2012 | 11506 | 0.200 |
Why?
|
Carboxypeptidases | 1 | 2002 | 121 | 0.200 |
Why?
|
Tissue Survival | 1 | 2002 | 121 | 0.200 |
Why?
|
Endothelial Growth Factors | 2 | 2002 | 680 | 0.200 |
Why?
|
Databases, Genetic | 2 | 2008 | 1751 | 0.200 |
Why?
|
Nuclear Proteins | 5 | 2012 | 5781 | 0.190 |
Why?
|
Embryonic Stem Cells | 1 | 2009 | 1242 | 0.190 |
Why?
|
Respiratory Tract Diseases | 1 | 2007 | 744 | 0.190 |
Why?
|
Lymphokines | 2 | 2002 | 911 | 0.190 |
Why?
|
Conflict of Interest | 1 | 2006 | 556 | 0.190 |
Why?
|
Nucleoside-Phosphate Kinase | 1 | 2001 | 24 | 0.190 |
Why?
|
Financing, Government | 3 | 2009 | 473 | 0.180 |
Why?
|
Avian Sarcoma Viruses | 3 | 1997 | 77 | 0.180 |
Why?
|
Survival Rate | 1 | 2015 | 12821 | 0.180 |
Why?
|
Femoral Artery | 8 | 2004 | 840 | 0.180 |
Why?
|
Health Care Reform | 1 | 2010 | 1258 | 0.180 |
Why?
|
beta-Galactosidase | 6 | 1997 | 572 | 0.180 |
Why?
|
Culture Media, Serum-Free | 3 | 2009 | 148 | 0.180 |
Why?
|
Nitroglycerin | 8 | 2001 | 331 | 0.180 |
Why?
|
Regeneration | 1 | 2009 | 1516 | 0.170 |
Why?
|
Societies, Medical | 2 | 2014 | 3950 | 0.170 |
Why?
|
Farnesyltranstransferase | 2 | 2012 | 70 | 0.170 |
Why?
|
Enzyme Inhibitors | 4 | 2008 | 3716 | 0.170 |
Why?
|
Health Care Costs | 1 | 2013 | 3240 | 0.170 |
Why?
|
Renin-Angiotensin System | 3 | 2002 | 737 | 0.170 |
Why?
|
Genes, MHC Class I | 5 | 1996 | 236 | 0.170 |
Why?
|
Lamin Type A | 5 | 2012 | 186 | 0.170 |
Why?
|
Anemia, Sickle Cell | 1 | 2008 | 1062 | 0.160 |
Why?
|
Phosphorylation | 6 | 2012 | 8278 | 0.160 |
Why?
|
Women's Health | 2 | 2006 | 2082 | 0.160 |
Why?
|
Warfarin | 1 | 2008 | 1494 | 0.160 |
Why?
|
Base Sequence | 15 | 2007 | 12402 | 0.160 |
Why?
|
Energy Metabolism | 1 | 2010 | 2891 | 0.160 |
Why?
|
Chronic Disease | 4 | 2009 | 9355 | 0.150 |
Why?
|
DNA Replication | 1 | 2005 | 1432 | 0.150 |
Why?
|
Stem Cells | 2 | 2009 | 3539 | 0.150 |
Why?
|
Lung | 5 | 2011 | 10031 | 0.150 |
Why?
|
Peripheral Vascular Diseases | 1 | 2001 | 520 | 0.150 |
Why?
|
Genes, Immediate-Early | 1 | 1998 | 102 | 0.150 |
Why?
|
Mice, Knockout | 13 | 2014 | 14445 | 0.150 |
Why?
|
Monitoring, Physiologic | 14 | 1989 | 1794 | 0.150 |
Why?
|
Ebolavirus | 4 | 2005 | 250 | 0.150 |
Why?
|
Ganciclovir | 6 | 2001 | 256 | 0.150 |
Why?
|
Coronary Artery Disease | 8 | 2010 | 6544 | 0.150 |
Why?
|
Attitude to Health | 1 | 2006 | 2019 | 0.150 |
Why?
|
Thrombosis | 3 | 2007 | 2956 | 0.140 |
Why?
|
Cell Proliferation | 3 | 2016 | 10428 | 0.140 |
Why?
|
Electrocardiography | 16 | 1989 | 6408 | 0.140 |
Why?
|
Obesity | 3 | 2010 | 13078 | 0.140 |
Why?
|
Ductus Arteriosus, Patent | 1 | 1999 | 214 | 0.140 |
Why?
|
Calcitonin Gene-Related Peptide | 1 | 2000 | 331 | 0.140 |
Why?
|
Endothelins | 1 | 1997 | 127 | 0.140 |
Why?
|
Disease Models, Animal | 15 | 2012 | 18289 | 0.140 |
Why?
|
Bone Marrow Cells | 1 | 2004 | 2412 | 0.140 |
Why?
|
Protein Processing, Post-Translational | 2 | 2002 | 1959 | 0.130 |
Why?
|
Developing Countries | 1 | 2009 | 2913 | 0.130 |
Why?
|
Tunica Intima | 6 | 2011 | 455 | 0.130 |
Why?
|
Myocardial Ischemia | 2 | 2004 | 2129 | 0.130 |
Why?
|
Microfilament Proteins | 2 | 2003 | 1130 | 0.130 |
Why?
|
Mitogens | 2 | 1995 | 228 | 0.130 |
Why?
|
Coronary Circulation | 4 | 1990 | 1602 | 0.130 |
Why?
|
Pulmonary Artery | 4 | 2005 | 1935 | 0.130 |
Why?
|
Health Planning | 2 | 2007 | 233 | 0.130 |
Why?
|
Proteomics | 2 | 2007 | 3909 | 0.130 |
Why?
|
Soccer | 1 | 2018 | 142 | 0.130 |
Why?
|
DNA Primers | 7 | 2007 | 2823 | 0.130 |
Why?
|
Hyperplasia | 5 | 2003 | 1146 | 0.130 |
Why?
|
DNA | 7 | 2002 | 7197 | 0.130 |
Why?
|
Vasodilation | 5 | 2001 | 970 | 0.130 |
Why?
|
Acetylcholine | 7 | 2001 | 626 | 0.120 |
Why?
|
Sports Medicine | 1 | 2018 | 239 | 0.120 |
Why?
|
Organizational Policy | 2 | 2009 | 434 | 0.120 |
Why?
|
Carrier Proteins | 2 | 2000 | 4911 | 0.120 |
Why?
|
Fibronectins | 1 | 1999 | 720 | 0.120 |
Why?
|
Delivery of Health Care | 3 | 2009 | 5368 | 0.120 |
Why?
|
Signal Transduction | 8 | 2016 | 23588 | 0.120 |
Why?
|
Alkaline Phosphatase | 5 | 1998 | 855 | 0.120 |
Why?
|
Hypoglycemic Agents | 1 | 2007 | 3107 | 0.120 |
Why?
|
Pulmonary Circulation | 1 | 1997 | 742 | 0.110 |
Why?
|
Angioplasty, Balloon | 6 | 2001 | 620 | 0.110 |
Why?
|
Recombinant Proteins | 7 | 1997 | 6489 | 0.110 |
Why?
|
Catheters, Indwelling | 2 | 1994 | 438 | 0.110 |
Why?
|
Venous Thromboembolism | 1 | 2007 | 1883 | 0.110 |
Why?
|
Oligonucleotides, Antisense | 1 | 1997 | 462 | 0.110 |
Why?
|
Pressoreceptors | 3 | 1990 | 98 | 0.110 |
Why?
|
Phenotype | 6 | 2012 | 16706 | 0.110 |
Why?
|
Contract Services | 1 | 2013 | 90 | 0.110 |
Why?
|
Fibroblast Growth Factor 1 | 1 | 1993 | 53 | 0.110 |
Why?
|
Ischemia | 2 | 2002 | 1922 | 0.110 |
Why?
|
Models, Cardiovascular | 2 | 2002 | 979 | 0.110 |
Why?
|
Stem Cell Transplantation | 1 | 2002 | 1601 | 0.110 |
Why?
|
Drug Delivery Systems | 2 | 2002 | 2210 | 0.110 |
Why?
|
Iliac Artery | 5 | 2002 | 352 | 0.110 |
Why?
|
Forecasting | 3 | 2007 | 2938 | 0.100 |
Why?
|
Molecular Sequence Data | 12 | 2012 | 17595 | 0.100 |
Why?
|
Electrophoretic Mobility Shift Assay | 3 | 2007 | 295 | 0.100 |
Why?
|
Education | 2 | 2005 | 531 | 0.100 |
Why?
|
DNA-Binding Proteins | 4 | 2006 | 9594 | 0.100 |
Why?
|
Anticoagulants | 1 | 2008 | 4862 | 0.100 |
Why?
|
Blood Vessels | 4 | 1999 | 1114 | 0.100 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 1 | 2007 | 3247 | 0.100 |
Why?
|
Protein Structure, Tertiary | 3 | 2010 | 3749 | 0.090 |
Why?
|
Cardiology | 2 | 2004 | 1700 | 0.090 |
Why?
|
Ductus Arteriosus | 1 | 2011 | 42 | 0.090 |
Why?
|
History, 18th Century | 1 | 2012 | 206 | 0.090 |
Why?
|
Genes, Reporter | 4 | 2006 | 1524 | 0.090 |
Why?
|
G1 Phase | 2 | 2005 | 403 | 0.090 |
Why?
|
Epithelial-Mesenchymal Transition | 1 | 2016 | 750 | 0.090 |
Why?
|
3T3 Cells | 3 | 2002 | 1081 | 0.090 |
Why?
|
Protein Prenylation | 1 | 2011 | 69 | 0.090 |
Why?
|
Cost Control | 1 | 2013 | 625 | 0.090 |
Why?
|
Rabbits | 8 | 2002 | 4731 | 0.090 |
Why?
|
Testis | 2 | 2001 | 781 | 0.090 |
Why?
|
Syndrome | 3 | 2007 | 3269 | 0.090 |
Why?
|
Genes | 2 | 1994 | 1824 | 0.090 |
Why?
|
Mental Health | 1 | 2005 | 3271 | 0.090 |
Why?
|
Genetics, Medical | 2 | 2011 | 334 | 0.090 |
Why?
|
Aorta | 5 | 2010 | 2037 | 0.090 |
Why?
|
Diet, Atherogenic | 1 | 2010 | 91 | 0.090 |
Why?
|
Captopril | 1 | 1991 | 261 | 0.090 |
Why?
|
Endothelial Cells | 2 | 2016 | 3584 | 0.090 |
Why?
|
Guidelines as Topic | 2 | 2007 | 1393 | 0.090 |
Why?
|
Female | 53 | 2015 | 396050 | 0.090 |
Why?
|
Vascular Endothelial Growth Factors | 2 | 2002 | 754 | 0.080 |
Why?
|
Chromosomes, Human, Pair 12 | 1 | 2011 | 432 | 0.080 |
Why?
|
Physicians | 1 | 2008 | 4587 | 0.080 |
Why?
|
Glycogen | 1 | 2010 | 251 | 0.080 |
Why?
|
Galactosidases | 1 | 1989 | 55 | 0.080 |
Why?
|
Centrosome | 1 | 2011 | 209 | 0.080 |
Why?
|
Sleep | 1 | 2005 | 4819 | 0.080 |
Why?
|
Transforming Growth Factor beta | 2 | 2016 | 1994 | 0.080 |
Why?
|
Heart Diseases | 3 | 2007 | 2818 | 0.080 |
Why?
|
Cell Adhesion Molecules, Neuronal | 1 | 2011 | 262 | 0.080 |
Why?
|
Reflex | 2 | 1990 | 376 | 0.080 |
Why?
|
History, 19th Century | 1 | 2012 | 711 | 0.080 |
Why?
|
Vasculitis | 2 | 1998 | 523 | 0.080 |
Why?
|
GPI-Linked Proteins | 1 | 2011 | 472 | 0.080 |
Why?
|
NF-kappa B | 4 | 2011 | 2487 | 0.080 |
Why?
|
Angioplasty | 1 | 2012 | 357 | 0.080 |
Why?
|
Genotype | 4 | 2008 | 13023 | 0.080 |
Why?
|
Macrophages, Alveolar | 1 | 2011 | 413 | 0.080 |
Why?
|
Viral Envelope Proteins | 2 | 2005 | 639 | 0.080 |
Why?
|
Proto-Oncogene Proteins c-sis | 3 | 1995 | 254 | 0.080 |
Why?
|
Blood Cells | 1 | 2011 | 307 | 0.080 |
Why?
|
Hypertension, Pulmonary | 1 | 2000 | 1603 | 0.080 |
Why?
|
Hemostasis | 2 | 2007 | 467 | 0.080 |
Why?
|
Male | 58 | 2015 | 363740 | 0.080 |
Why?
|
Fetal Proteins | 1 | 2009 | 99 | 0.080 |
Why?
|
Plasminogen Activator Inhibitor 1 | 2 | 2000 | 279 | 0.080 |
Why?
|
Models, Genetic | 2 | 2001 | 3447 | 0.080 |
Why?
|
Semaphorins | 1 | 2009 | 96 | 0.080 |
Why?
|
Cholesterol, LDL | 2 | 2012 | 2393 | 0.080 |
Why?
|
International Agencies | 1 | 2009 | 241 | 0.080 |
Why?
|
Recombinant Fusion Proteins | 4 | 2006 | 3736 | 0.080 |
Why?
|
Membrane Glycoproteins | 4 | 2001 | 3690 | 0.080 |
Why?
|
Myocardium | 4 | 2003 | 4763 | 0.070 |
Why?
|
Ovary | 1 | 1992 | 957 | 0.070 |
Why?
|
Wound Healing | 3 | 2008 | 2792 | 0.070 |
Why?
|
Breast Neoplasms | 2 | 2013 | 21064 | 0.070 |
Why?
|
Interinstitutional Relations | 1 | 2009 | 234 | 0.070 |
Why?
|
Managed Care Programs | 1 | 2013 | 934 | 0.070 |
Why?
|
Tissue Plasminogen Activator | 2 | 1991 | 1166 | 0.070 |
Why?
|
Biliverdine | 1 | 2007 | 28 | 0.070 |
Why?
|
Gene Expression Regulation, Developmental | 3 | 2012 | 3604 | 0.070 |
Why?
|
Methylation | 1 | 2010 | 1075 | 0.070 |
Why?
|
Peptidyl-Dipeptidase A | 2 | 2002 | 323 | 0.070 |
Why?
|
Athletic Injuries | 1 | 2018 | 1244 | 0.070 |
Why?
|
Polymerase Chain Reaction | 4 | 2007 | 6061 | 0.070 |
Why?
|
Cardiac Pacing, Artificial | 2 | 1990 | 882 | 0.070 |
Why?
|
Cell Line | 9 | 2009 | 15540 | 0.070 |
Why?
|
Gene Deletion | 3 | 2006 | 2667 | 0.070 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2008 | 431 | 0.070 |
Why?
|
Receptor Protein-Tyrosine Kinases | 1 | 2014 | 1621 | 0.070 |
Why?
|
Electrophoresis, Gel, Two-Dimensional | 1 | 2007 | 283 | 0.070 |
Why?
|
Endocardium | 1 | 1988 | 249 | 0.070 |
Why?
|
Kidney | 3 | 2001 | 7073 | 0.070 |
Why?
|
Genome-Wide Association Study | 3 | 2011 | 12800 | 0.070 |
Why?
|
Cardiac Volume | 1 | 1987 | 196 | 0.070 |
Why?
|
Physicians, Primary Care | 1 | 2013 | 622 | 0.070 |
Why?
|
Muscle, Skeletal | 1 | 2002 | 4961 | 0.070 |
Why?
|
Protein O-Methyltransferase | 1 | 2006 | 3 | 0.070 |
Why?
|
Blotting, Western | 4 | 2006 | 5018 | 0.070 |
Why?
|
Brain Concussion | 1 | 2018 | 1432 | 0.070 |
Why?
|
T-Box Domain Proteins | 1 | 2009 | 469 | 0.070 |
Why?
|
Cytotoxicity, Immunologic | 4 | 2001 | 1347 | 0.070 |
Why?
|
Retroviridae | 4 | 1994 | 847 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor Receptor-2 | 1 | 2009 | 548 | 0.070 |
Why?
|
Herpesviridae | 3 | 1996 | 104 | 0.060 |
Why?
|
Information Services | 1 | 2007 | 240 | 0.060 |
Why?
|
Mice, Transgenic | 4 | 2012 | 9548 | 0.060 |
Why?
|
Rats | 10 | 1997 | 23707 | 0.060 |
Why?
|
Fibroblasts | 3 | 2012 | 4160 | 0.060 |
Why?
|
RNA, Small Interfering | 2 | 2007 | 3418 | 0.060 |
Why?
|
Mitosis | 1 | 2011 | 1175 | 0.060 |
Why?
|
Thromboplastin | 1 | 2007 | 289 | 0.060 |
Why?
|
Time Factors | 11 | 2011 | 40109 | 0.060 |
Why?
|
Health Education | 3 | 2007 | 1060 | 0.060 |
Why?
|
Autoimmunity | 2 | 1994 | 1354 | 0.060 |
Why?
|
RNA, Messenger | 7 | 2004 | 12767 | 0.060 |
Why?
|
International Cooperation | 2 | 2009 | 1432 | 0.060 |
Why?
|
Research Design | 4 | 2005 | 6207 | 0.060 |
Why?
|
Hemorrhagic Fever, Ebola | 3 | 2000 | 424 | 0.060 |
Why?
|
Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 1 | 2007 | 506 | 0.060 |
Why?
|
Protein-Tyrosine Kinases | 1 | 2014 | 2423 | 0.060 |
Why?
|
Melanoma | 6 | 1996 | 5696 | 0.060 |
Why?
|
Membrane Microdomains | 1 | 2006 | 203 | 0.060 |
Why?
|
Polymorphism, Genetic | 2 | 2008 | 4249 | 0.060 |
Why?
|
Oxidative Stress | 3 | 2016 | 3139 | 0.060 |
Why?
|
Aging | 4 | 2011 | 8731 | 0.060 |
Why?
|
Extracellular Matrix | 3 | 2001 | 1726 | 0.060 |
Why?
|
Fibrin Fibrinogen Degradation Products | 1 | 2007 | 427 | 0.060 |
Why?
|
Financial Management | 1 | 2006 | 161 | 0.060 |
Why?
|
Cyclin-Dependent Kinase Inhibitor p16 | 2 | 2000 | 702 | 0.060 |
Why?
|
Muscle Development | 2 | 1997 | 258 | 0.060 |
Why?
|
Telomere | 1 | 2011 | 941 | 0.060 |
Why?
|
Heart Rate | 8 | 1991 | 4202 | 0.060 |
Why?
|
Appetite Regulation | 1 | 2005 | 84 | 0.060 |
Why?
|
Thrombolytic Therapy | 2 | 1991 | 2059 | 0.060 |
Why?
|
Exercise Test | 8 | 2001 | 2184 | 0.060 |
Why?
|
Lipopolysaccharides | 2 | 2011 | 2213 | 0.060 |
Why?
|
Hypertension, Renovascular | 1 | 1985 | 121 | 0.060 |
Why?
|
Two-Hybrid System Techniques | 1 | 2005 | 463 | 0.060 |
Why?
|
Industry | 1 | 2006 | 362 | 0.060 |
Why?
|
Teratocarcinoma | 1 | 2004 | 16 | 0.060 |
Why?
|
Coronary Angiography | 9 | 2000 | 4497 | 0.060 |
Why?
|
Integrin alphaVbeta3 | 1 | 2005 | 102 | 0.060 |
Why?
|
Catheterization, Peripheral | 3 | 1996 | 349 | 0.060 |
Why?
|
Professional Autonomy | 1 | 2005 | 172 | 0.060 |
Why?
|
Administration, Inhalation | 1 | 2007 | 1154 | 0.060 |
Why?
|
Transgenes | 4 | 2006 | 1015 | 0.060 |
Why?
|
Genetic Predisposition to Disease | 3 | 2011 | 18064 | 0.060 |
Why?
|
Inflammation | 3 | 2005 | 10845 | 0.060 |
Why?
|
Dynamins | 1 | 2005 | 138 | 0.060 |
Why?
|
Calcium | 2 | 2006 | 5767 | 0.060 |
Why?
|
Respiratory Physiological Phenomena | 1 | 2005 | 190 | 0.060 |
Why?
|
Diet, Fat-Restricted | 1 | 2006 | 328 | 0.060 |
Why?
|
Cold Temperature | 1 | 1988 | 794 | 0.060 |
Why?
|
Program Development | 1 | 2010 | 1296 | 0.060 |
Why?
|
Muscle Contraction | 2 | 2005 | 1206 | 0.060 |
Why?
|
Angiotensin II | 3 | 1997 | 844 | 0.060 |
Why?
|
Life Style | 2 | 2009 | 3929 | 0.050 |
Why?
|
Apoptosis | 5 | 2007 | 9512 | 0.050 |
Why?
|
Community-Institutional Relations | 1 | 2005 | 209 | 0.050 |
Why?
|
Eating | 1 | 2010 | 1538 | 0.050 |
Why?
|
Protein Binding | 2 | 2006 | 9297 | 0.050 |
Why?
|
Spirometry | 1 | 2007 | 928 | 0.050 |
Why?
|
von Willebrand Factor | 1 | 2007 | 676 | 0.050 |
Why?
|
Thymectomy | 1 | 2004 | 200 | 0.050 |
Why?
|
Fear | 1 | 2012 | 1496 | 0.050 |
Why?
|
Receptors, Retinoic Acid | 1 | 2004 | 229 | 0.050 |
Why?
|
Salaries and Fringe Benefits | 1 | 2005 | 259 | 0.050 |
Why?
|
Osteoporosis, Postmenopausal | 1 | 2006 | 399 | 0.050 |
Why?
|
Ion Channels | 1 | 1988 | 1044 | 0.050 |
Why?
|
Cyclin-Dependent Kinase 2 | 2 | 2000 | 185 | 0.050 |
Why?
|
Dose-Response Relationship, Drug | 6 | 2008 | 10723 | 0.050 |
Why?
|
Cyclic GMP | 2 | 2001 | 394 | 0.050 |
Why?
|
Toll-Like Receptors | 1 | 2006 | 583 | 0.050 |
Why?
|
Cooperative Behavior | 1 | 2010 | 1510 | 0.050 |
Why?
|
Enzyme Induction | 2 | 2001 | 456 | 0.050 |
Why?
|
Chloramphenicol O-Acetyltransferase | 2 | 2002 | 220 | 0.050 |
Why?
|
Inflammation Mediators | 1 | 2011 | 1885 | 0.050 |
Why?
|
Sodium | 1 | 1988 | 1591 | 0.050 |
Why?
|
Blood Physiological Phenomena | 1 | 2002 | 53 | 0.050 |
Why?
|
Phosphothreonine | 1 | 2002 | 62 | 0.050 |
Why?
|
Enzyme-Linked Immunosorbent Assay | 2 | 2007 | 3802 | 0.050 |
Why?
|
Angiotensins | 1 | 2002 | 139 | 0.050 |
Why?
|
Middle Aged | 33 | 2011 | 223016 | 0.050 |
Why?
|
Phosphoserine | 1 | 2002 | 203 | 0.050 |
Why?
|
Genetic Loci | 1 | 2011 | 2631 | 0.050 |
Why?
|
Proliferating Cell Nuclear Antigen | 1 | 2003 | 283 | 0.050 |
Why?
|
Risk | 2 | 2013 | 9600 | 0.050 |
Why?
|
Swine, Miniature | 4 | 1992 | 972 | 0.050 |
Why?
|
Liver | 3 | 2010 | 7558 | 0.050 |
Why?
|
Hemodynamics | 8 | 1994 | 4188 | 0.050 |
Why?
|
Cholesterol | 2 | 2010 | 2898 | 0.050 |
Why?
|
Mice, Inbred Strains | 1 | 2004 | 1770 | 0.050 |
Why?
|
Aged | 25 | 2011 | 171178 | 0.050 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2006 | 12235 | 0.050 |
Why?
|
Enzyme Activation | 1 | 2007 | 3585 | 0.050 |
Why?
|
Career Choice | 1 | 2008 | 769 | 0.050 |
Why?
|
S Phase | 2 | 2003 | 424 | 0.050 |
Why?
|
Recurrence | 3 | 2009 | 8506 | 0.050 |
Why?
|
H-2 Antigens | 3 | 1997 | 359 | 0.050 |
Why?
|
Glycoproteins | 2 | 2000 | 2195 | 0.050 |
Why?
|
Angiography | 5 | 1990 | 1599 | 0.050 |
Why?
|
HeLa Cells | 2 | 2006 | 3067 | 0.050 |
Why?
|
Ambulatory Care | 4 | 1988 | 2776 | 0.050 |
Why?
|
Physical Fitness | 1 | 2006 | 742 | 0.050 |
Why?
|
Infusions, Intra-Arterial | 1 | 2001 | 219 | 0.050 |
Why?
|
Evaluation Studies as Topic | 2 | 1997 | 1606 | 0.050 |
Why?
|
Risk Factors | 7 | 2012 | 74853 | 0.050 |
Why?
|
Cytoplasm | 2 | 2003 | 1497 | 0.050 |
Why?
|
Tretinoin | 1 | 2004 | 524 | 0.050 |
Why?
|
Protoporphyrins | 1 | 2001 | 167 | 0.040 |
Why?
|
Disclosure | 1 | 2006 | 756 | 0.040 |
Why?
|
Vasodilator Agents | 2 | 2000 | 988 | 0.040 |
Why?
|
Mice, Inbred BALB C | 8 | 2000 | 6219 | 0.040 |
Why?
|
Protein Transport | 2 | 2006 | 1937 | 0.040 |
Why?
|
Vascular Endothelial Growth Factor A | 2 | 2002 | 3503 | 0.040 |
Why?
|
Transduction, Genetic | 2 | 2002 | 898 | 0.040 |
Why?
|
Biological Therapy | 1 | 2002 | 140 | 0.040 |
Why?
|
Massachusetts | 1 | 2013 | 8875 | 0.040 |
Why?
|
Diabetes Complications | 1 | 2007 | 1318 | 0.040 |
Why?
|
Cyclin A | 1 | 2000 | 59 | 0.040 |
Why?
|
Acyclovir | 1 | 2001 | 266 | 0.040 |
Why?
|
Vitronectin | 1 | 2000 | 40 | 0.040 |
Why?
|
Students, Medical | 1 | 2013 | 1962 | 0.040 |
Why?
|
Patients | 1 | 2006 | 909 | 0.040 |
Why?
|
Injections, Intramuscular | 1 | 2001 | 553 | 0.040 |
Why?
|
Repressor Proteins | 1 | 2011 | 2971 | 0.040 |
Why?
|
Chromosomes, Human, Pair 1 | 1 | 2002 | 640 | 0.040 |
Why?
|
Transcriptional Activation | 1 | 2006 | 1743 | 0.040 |
Why?
|
Estrogen Replacement Therapy | 1 | 2006 | 1206 | 0.040 |
Why?
|
Binding Sites | 3 | 2005 | 5999 | 0.040 |
Why?
|
Histocompatibility Antigens Class I | 2 | 2005 | 1363 | 0.040 |
Why?
|
Coronary Artery Bypass | 1 | 2009 | 2188 | 0.040 |
Why?
|
Cyclin E | 1 | 2000 | 155 | 0.040 |
Why?
|
Angina, Unstable | 1 | 2004 | 893 | 0.040 |
Why?
|
Hindlimb | 1 | 2002 | 510 | 0.040 |
Why?
|
Body Weight | 1 | 2010 | 4624 | 0.040 |
Why?
|
Genetic Linkage | 1 | 2005 | 2341 | 0.040 |
Why?
|
Cations | 2 | 1997 | 239 | 0.040 |
Why?
|
Gene Expression Profiling | 3 | 2004 | 9520 | 0.040 |
Why?
|
Regional Blood Flow | 2 | 2001 | 1481 | 0.040 |
Why?
|
Multicenter Studies as Topic | 1 | 2004 | 1731 | 0.040 |
Why?
|
Untranslated Regions | 1 | 1998 | 30 | 0.040 |
Why?
|
Phosphodiesterase Inhibitors | 1 | 2000 | 213 | 0.040 |
Why?
|
Vasomotor System | 2 | 1990 | 208 | 0.040 |
Why?
|
Rats, Sprague-Dawley | 4 | 1997 | 8105 | 0.040 |
Why?
|
RNA, Untranslated | 1 | 2002 | 453 | 0.040 |
Why?
|
Neutrophils | 2 | 2004 | 3770 | 0.040 |
Why?
|
Predictive Value of Tests | 2 | 2005 | 15398 | 0.040 |
Why?
|
Reactive Oxygen Species | 1 | 2006 | 2141 | 0.040 |
Why?
|
Periodicals as Topic | 1 | 2009 | 1462 | 0.040 |
Why?
|
Drug Eruptions | 1 | 2001 | 334 | 0.040 |
Why?
|
Adaptation, Physiological | 1 | 2005 | 1308 | 0.040 |
Why?
|
Biolistics | 1 | 1997 | 15 | 0.040 |
Why?
|
Gene Frequency | 1 | 2005 | 3623 | 0.040 |
Why?
|
Graft Occlusion, Vascular | 1 | 2001 | 548 | 0.040 |
Why?
|
Propranolol | 2 | 1991 | 494 | 0.040 |
Why?
|
Chloramphenicol | 1 | 1997 | 67 | 0.040 |
Why?
|
Michigan | 1 | 1998 | 328 | 0.040 |
Why?
|
Drug Carriers | 3 | 1996 | 702 | 0.040 |
Why?
|
Neoplasms | 8 | 2007 | 22349 | 0.040 |
Why?
|
Angiotensin I | 1 | 1997 | 47 | 0.040 |
Why?
|
Edema | 1 | 2001 | 761 | 0.040 |
Why?
|
Receptors, LDL | 1 | 2000 | 491 | 0.040 |
Why?
|
Potassium Channels | 1 | 2000 | 534 | 0.030 |
Why?
|
Oligodeoxyribonucleotides | 1 | 1998 | 705 | 0.030 |
Why?
|
Choline O-Acetyltransferase | 1 | 1997 | 154 | 0.030 |
Why?
|
Sleep Apnea Syndromes | 1 | 2005 | 983 | 0.030 |
Why?
|
Software | 1 | 2011 | 4458 | 0.030 |
Why?
|
Tomography, Emission-Computed | 5 | 2001 | 1006 | 0.030 |
Why?
|
Viral Matrix Proteins | 1 | 1998 | 192 | 0.030 |
Why?
|
Acute Disease | 2 | 2004 | 7237 | 0.030 |
Why?
|
Safety | 3 | 2000 | 1158 | 0.030 |
Why?
|
Ethers | 1 | 1996 | 73 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 3 | 2011 | 4562 | 0.030 |
Why?
|
Amino Acid Substitution | 2 | 2014 | 1739 | 0.030 |
Why?
|
Phosphatidylethanolamines | 1 | 1996 | 129 | 0.030 |
Why?
|
Vaccines, DNA | 1 | 1998 | 279 | 0.030 |
Why?
|
Kidney Diseases | 1 | 2007 | 2097 | 0.030 |
Why?
|
Bone Marrow Transplantation | 1 | 2004 | 2729 | 0.030 |
Why?
|
Leg | 1 | 2001 | 1108 | 0.030 |
Why?
|
Cyclin-Dependent Kinase 4 | 1 | 2000 | 561 | 0.030 |
Why?
|
Acetyltransferases | 1 | 1997 | 229 | 0.030 |
Why?
|
Vasoconstrictor Agents | 1 | 2000 | 653 | 0.030 |
Why?
|
Hypercholesterolemia | 1 | 2003 | 1148 | 0.030 |
Why?
|
Internet | 1 | 2008 | 3104 | 0.030 |
Why?
|
Exercise Tolerance | 1 | 2001 | 841 | 0.030 |
Why?
|
Sheep | 1 | 1999 | 1440 | 0.030 |
Why?
|
Immunohistochemistry | 5 | 2011 | 11033 | 0.030 |
Why?
|
Culture Media, Conditioned | 1 | 1997 | 521 | 0.030 |
Why?
|
Stroke | 2 | 2009 | 9749 | 0.030 |
Why?
|
Quaternary Ammonium Compounds | 1 | 1996 | 204 | 0.030 |
Why?
|
Genetic Engineering | 2 | 1992 | 933 | 0.030 |
Why?
|
Renal Artery | 1 | 1997 | 364 | 0.030 |
Why?
|
Moloney murine leukemia virus | 2 | 1998 | 110 | 0.030 |
Why?
|
Endothelin-1 | 1 | 1997 | 295 | 0.030 |
Why?
|
Sleep Initiation and Maintenance Disorders | 1 | 2005 | 1102 | 0.030 |
Why?
|
Carotid Arteries | 4 | 2005 | 937 | 0.030 |
Why?
|
Vasopressins | 2 | 1988 | 359 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 1996 | 329 | 0.030 |
Why?
|
Smoking Cessation | 1 | 2007 | 2084 | 0.030 |
Why?
|
Fas Ligand Protein | 3 | 2001 | 214 | 0.030 |
Why?
|
Hematopoietic Stem Cells | 1 | 2007 | 3406 | 0.030 |
Why?
|
Leukocytes, Mononuclear | 1 | 2002 | 1856 | 0.030 |
Why?
|
Antineoplastic Agents | 2 | 2011 | 13635 | 0.030 |
Why?
|
Transcription, Genetic | 3 | 2006 | 7599 | 0.030 |
Why?
|
Pilot Projects | 2 | 2007 | 8725 | 0.030 |
Why?
|
Genes, Retinoblastoma | 1 | 1995 | 125 | 0.030 |
Why?
|
Cell Differentiation | 3 | 2009 | 11643 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2007 | 14644 | 0.030 |
Why?
|
Mutation | 3 | 2012 | 30188 | 0.030 |
Why?
|
Growth Inhibitors | 1 | 1995 | 375 | 0.030 |
Why?
|
Activities of Daily Living | 5 | 1991 | 2415 | 0.030 |
Why?
|
Virus Physiological Phenomena | 1 | 1994 | 15 | 0.030 |
Why?
|
Health Behavior | 1 | 2006 | 2649 | 0.030 |
Why?
|
Neural Pathways | 1 | 2005 | 3087 | 0.030 |
Why?
|
Sirolimus | 1 | 2001 | 1544 | 0.030 |
Why?
|
Carotid Artery, Common | 1 | 1995 | 173 | 0.030 |
Why?
|
Adult | 23 | 2002 | 223055 | 0.030 |
Why?
|
Prognosis | 6 | 2007 | 29915 | 0.030 |
Why?
|
Endothelium | 2 | 1994 | 768 | 0.030 |
Why?
|
Viral Proteins | 2 | 1998 | 1798 | 0.030 |
Why?
|
Lymphocytes, Tumor-Infiltrating | 2 | 1996 | 1104 | 0.030 |
Why?
|
Paclitaxel | 1 | 2001 | 1726 | 0.030 |
Why?
|
Health Promotion | 1 | 2006 | 2208 | 0.030 |
Why?
|
Echocardiography | 2 | 2002 | 5042 | 0.030 |
Why?
|
Histocytochemistry | 1 | 1994 | 695 | 0.030 |
Why?
|
Sympathetic Nervous System | 2 | 1988 | 521 | 0.030 |
Why?
|
Glutathione Peroxidase | 1 | 2014 | 256 | 0.030 |
Why?
|
T-Lymphocytes | 3 | 2004 | 10262 | 0.030 |
Why?
|
Arrhythmias, Cardiac | 1 | 2003 | 2255 | 0.030 |
Why?
|
Genetic Variation | 1 | 2008 | 6607 | 0.030 |
Why?
|
Cell Death | 1 | 1998 | 1678 | 0.030 |
Why?
|
Procollagen | 1 | 1993 | 189 | 0.030 |
Why?
|
Macrophages | 2 | 2006 | 5771 | 0.030 |
Why?
|
I-kappa B Proteins | 1 | 1993 | 209 | 0.030 |
Why?
|
Congresses as Topic | 1 | 2018 | 811 | 0.030 |
Why?
|
Primary Prevention | 1 | 2000 | 1187 | 0.030 |
Why?
|
Vitamin D | 1 | 2006 | 3272 | 0.030 |
Why?
|
Drug Administration Routes | 1 | 1992 | 152 | 0.030 |
Why?
|
Receptors, Antigen, T-Cell, alpha-beta | 1 | 1996 | 813 | 0.030 |
Why?
|
Heart | 6 | 1994 | 4419 | 0.030 |
Why?
|
Neoplasms, Experimental | 1 | 1997 | 1230 | 0.030 |
Why?
|
Fluorodeoxyglucose F18 | 1 | 2001 | 2027 | 0.030 |
Why?
|
Carotid Stenosis | 1 | 2000 | 868 | 0.030 |
Why?
|
Viral Vaccines | 1 | 1998 | 597 | 0.020 |
Why?
|
Patient Selection | 1 | 2004 | 4257 | 0.020 |
Why?
|
Brain | 2 | 2012 | 27178 | 0.020 |
Why?
|
Hyperkinesis | 1 | 2012 | 88 | 0.020 |
Why?
|
Cell Line, Tumor | 2 | 2006 | 17063 | 0.020 |
Why?
|
Viruses | 1 | 1996 | 370 | 0.020 |
Why?
|
Health Status | 1 | 2005 | 4084 | 0.020 |
Why?
|
Physical Exertion | 4 | 1988 | 666 | 0.020 |
Why?
|
Collagen Type VI | 1 | 2011 | 26 | 0.020 |
Why?
|
Pulmonary Alveoli | 1 | 1994 | 664 | 0.020 |
Why?
|
Factor IX | 1 | 1991 | 76 | 0.020 |
Why?
|
Lower Body Negative Pressure | 2 | 1990 | 23 | 0.020 |
Why?
|
Telomeric Repeat Binding Protein 2 | 1 | 2011 | 20 | 0.020 |
Why?
|
Immunoblotting | 2 | 2006 | 1643 | 0.020 |
Why?
|
Health Personnel | 1 | 2005 | 3386 | 0.020 |
Why?
|
Radiopharmaceuticals | 1 | 2001 | 2700 | 0.020 |
Why?
|
Wounds, Nonpenetrating | 1 | 1998 | 806 | 0.020 |
Why?
|
Postmenopause | 1 | 2000 | 2517 | 0.020 |
Why?
|
Dose-Response Relationship, Immunologic | 1 | 2011 | 355 | 0.020 |
Why?
|
Lamin Type B | 1 | 2011 | 28 | 0.020 |
Why?
|
DNA, Single-Stranded | 1 | 1993 | 353 | 0.020 |
Why?
|
Nitric Oxide | 1 | 2000 | 2143 | 0.020 |
Why?
|
Treatment Outcome | 3 | 2004 | 65223 | 0.020 |
Why?
|
Simplexvirus | 1 | 1995 | 806 | 0.020 |
Why?
|
Genes, Tumor Suppressor | 1 | 1995 | 1061 | 0.020 |
Why?
|
Communication | 1 | 2005 | 3906 | 0.020 |
Why?
|
Recombination, Genetic | 1 | 1995 | 1525 | 0.020 |
Why?
|
Cell Survival | 2 | 2006 | 5747 | 0.020 |
Why?
|
Cardiomyopathies | 1 | 2003 | 2066 | 0.020 |
Why?
|
Practice Guidelines as Topic | 1 | 2008 | 7416 | 0.020 |
Why?
|
Papaverine | 1 | 1990 | 45 | 0.020 |
Why?
|
Administration, Cutaneous | 2 | 1991 | 715 | 0.020 |
Why?
|
Tumor Cells, Cultured | 4 | 2000 | 6110 | 0.020 |
Why?
|
Methods | 1 | 1990 | 1061 | 0.020 |
Why?
|
Venous Thrombosis | 1 | 2000 | 1327 | 0.020 |
Why?
|
Genetic Testing | 1 | 2003 | 3590 | 0.020 |
Why?
|
Hep G2 Cells | 1 | 2011 | 379 | 0.020 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2011 | 16040 | 0.020 |
Why?
|
Oxygen Consumption | 1 | 2016 | 1870 | 0.020 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 1996 | 1801 | 0.020 |
Why?
|
Secondary Prevention | 1 | 1996 | 1471 | 0.020 |
Why?
|
Placenta | 2 | 1998 | 1725 | 0.020 |
Why?
|
Extracellular Matrix Proteins | 1 | 1993 | 833 | 0.020 |
Why?
|
Immunotherapy | 3 | 1994 | 4752 | 0.020 |
Why?
|
Blood Circulation | 1 | 1990 | 248 | 0.020 |
Why?
|
Diabetes Mellitus | 1 | 2007 | 5889 | 0.020 |
Why?
|
DNA, Viral | 1 | 1996 | 2199 | 0.020 |
Why?
|
Gene Expression Regulation, Viral | 1 | 1991 | 435 | 0.020 |
Why?
|
Muscles | 1 | 1994 | 1578 | 0.020 |
Why?
|
Government Agencies | 1 | 2009 | 161 | 0.020 |
Why?
|
Fibroblast Growth Factors | 1 | 1995 | 871 | 0.020 |
Why?
|
Lymphocytes | 1 | 1996 | 2601 | 0.020 |
Why?
|
Hypertension | 2 | 2003 | 8625 | 0.020 |
Why?
|
Dogs | 2 | 2002 | 3824 | 0.020 |
Why?
|
Tissue Distribution | 1 | 1992 | 2270 | 0.020 |
Why?
|
Oxidation-Reduction | 1 | 2014 | 2219 | 0.020 |
Why?
|
Epoprostenol | 1 | 1989 | 246 | 0.020 |
Why?
|
Ion Exchange | 1 | 1988 | 16 | 0.020 |
Why?
|
Membrane Proteins | 2 | 2005 | 7846 | 0.020 |
Why?
|
Electrocardiography, Ambulatory | 1 | 1991 | 582 | 0.020 |
Why?
|
Cardiomegaly | 1 | 1991 | 589 | 0.020 |
Why?
|
Consensus | 1 | 2018 | 3199 | 0.020 |
Why?
|
Tachycardia | 1 | 1990 | 597 | 0.020 |
Why?
|
Double-Blind Method | 3 | 1991 | 12421 | 0.020 |
Why?
|
Rubidium | 1 | 1987 | 120 | 0.020 |
Why?
|
Verapamil | 1 | 1988 | 242 | 0.020 |
Why?
|
Arginine Vasopressin | 1 | 1987 | 125 | 0.020 |
Why?
|
Atrial Function | 1 | 1987 | 98 | 0.020 |
Why?
|
Drug Tolerance | 1 | 1989 | 365 | 0.020 |
Why?
|
Cell Adhesion Molecules | 1 | 1993 | 1610 | 0.020 |
Why?
|
Cell Lineage | 1 | 2016 | 2573 | 0.020 |
Why?
|
Atrial Natriuretic Factor | 1 | 1988 | 347 | 0.020 |
Why?
|
Urbanization | 1 | 2007 | 100 | 0.020 |
Why?
|
Receptors, Adrenergic, beta | 1 | 1988 | 242 | 0.020 |
Why?
|
Circadian Rhythm | 3 | 1987 | 2595 | 0.020 |
Why?
|
Pregnancy | 3 | 2011 | 30215 | 0.020 |
Why?
|
Colorectal Neoplasms | 1 | 2006 | 6960 | 0.020 |
Why?
|
Rheology | 1 | 1988 | 348 | 0.020 |
Why?
|
Algorithms | 1 | 2007 | 14062 | 0.020 |
Why?
|
Neoplasms, Second Primary | 1 | 1994 | 1056 | 0.020 |
Why?
|
Down-Regulation | 2 | 2005 | 2924 | 0.020 |
Why?
|
Mice, Inbred C57BL | 4 | 2011 | 22323 | 0.020 |
Why?
|
Immunity, Cellular | 1 | 1992 | 1553 | 0.020 |
Why?
|
Disease Progression | 3 | 2008 | 13613 | 0.020 |
Why?
|
Organ Culture Techniques | 2 | 1998 | 788 | 0.020 |
Why?
|
Blood Flow Velocity | 1 | 1990 | 1382 | 0.020 |
Why?
|
Lipids | 1 | 1997 | 3316 | 0.020 |
Why?
|
Infusions, Intravenous | 1 | 1991 | 2226 | 0.020 |
Why?
|
Telomerase | 1 | 2011 | 749 | 0.020 |
Why?
|
Blood Chemical Analysis | 1 | 2008 | 434 | 0.020 |
Why?
|
Chromosomes, Artificial, Bacterial | 1 | 2006 | 125 | 0.020 |
Why?
|
Growth | 1 | 2008 | 365 | 0.020 |
Why?
|
Blood Vessel Prosthesis | 1 | 1991 | 959 | 0.020 |
Why?
|
Fluorescein-5-isothiocyanate | 1 | 2006 | 220 | 0.020 |
Why?
|
Renin | 1 | 1988 | 647 | 0.020 |
Why?
|
Ventricular Function | 1 | 1987 | 403 | 0.020 |
Why?
|
Injections, Intravenous | 2 | 2002 | 1375 | 0.020 |
Why?
|
Radioisotopes | 1 | 1987 | 498 | 0.020 |
Why?
|
Norepinephrine | 1 | 1988 | 898 | 0.020 |
Why?
|
Precipitin Tests | 1 | 2006 | 812 | 0.020 |
Why?
|
Mutation, Missense | 1 | 2014 | 2586 | 0.020 |
Why?
|
Antigens | 1 | 2011 | 1438 | 0.020 |
Why?
|
Collagen | 1 | 1993 | 2617 | 0.020 |
Why?
|
Quinolones | 1 | 2008 | 387 | 0.010 |
Why?
|
Ouabain | 1 | 1985 | 246 | 0.010 |
Why?
|
Plaque, Atherosclerotic | 1 | 2016 | 1529 | 0.010 |
Why?
|
Pericardium | 1 | 1989 | 679 | 0.010 |
Why?
|
NIH 3T3 Cells | 1 | 2006 | 651 | 0.010 |
Why?
|
Behavior, Animal | 1 | 2012 | 1866 | 0.010 |
Why?
|
Random Allocation | 1 | 1989 | 2394 | 0.010 |
Why?
|
Luciferases | 1 | 2006 | 713 | 0.010 |
Why?
|
Cohort Studies | 1 | 2007 | 41643 | 0.010 |
Why?
|
Tumor Necrosis Factor-alpha | 3 | 2006 | 4350 | 0.010 |
Why?
|
Up-Regulation | 2 | 2004 | 4133 | 0.010 |
Why?
|
Immunoprecipitation | 1 | 2006 | 871 | 0.010 |
Why?
|
Pyrazoles | 1 | 2014 | 2031 | 0.010 |
Why?
|
Glutathione Transferase | 1 | 2006 | 562 | 0.010 |
Why?
|
Microscopy, Electron, Transmission | 1 | 2006 | 684 | 0.010 |
Why?
|
Models, Organizational | 1 | 2007 | 548 | 0.010 |
Why?
|
S-Phase Kinase-Associated Proteins | 1 | 2004 | 84 | 0.010 |
Why?
|
Proteins | 1 | 1998 | 5996 | 0.010 |
Why?
|
Antiviral Agents | 1 | 1996 | 3051 | 0.010 |
Why?
|
Mathematics | 1 | 2005 | 696 | 0.010 |
Why?
|
Drug Therapy, Combination | 2 | 1991 | 6304 | 0.010 |
Why?
|
Reference Values | 2 | 1989 | 4911 | 0.010 |
Why?
|
Alanine | 1 | 2006 | 613 | 0.010 |
Why?
|
Feasibility Studies | 1 | 1994 | 5302 | 0.010 |
Why?
|
Cardiovascular Agents | 1 | 1989 | 850 | 0.010 |
Why?
|
Actins | 1 | 1990 | 2057 | 0.010 |
Why?
|
Blood Pressure | 3 | 2006 | 8532 | 0.010 |
Why?
|
Neovascularization, Pathologic | 1 | 1993 | 2629 | 0.010 |
Why?
|
Protein Synthesis Inhibitors | 1 | 2003 | 187 | 0.010 |
Why?
|
Pyridines | 1 | 2014 | 2887 | 0.010 |
Why?
|
Dactinomycin | 1 | 2003 | 304 | 0.010 |
Why?
|
Restriction Mapping | 2 | 1994 | 848 | 0.010 |
Why?
|
Cycloheximide | 1 | 2003 | 339 | 0.010 |
Why?
|
Ubiquitins | 1 | 2004 | 365 | 0.010 |
Why?
|
Motor Activity | 1 | 2012 | 2705 | 0.010 |
Why?
|
Cell-Free System | 1 | 2003 | 339 | 0.010 |
Why?
|
Diet | 1 | 2000 | 8085 | 0.010 |
Why?
|
Amino Acid Transport Systems, Basic | 1 | 2002 | 35 | 0.010 |
Why?
|
Fluorescent Antibody Technique, Indirect | 1 | 2003 | 425 | 0.010 |
Why?
|
Triage | 1 | 1989 | 994 | 0.010 |
Why?
|
Heart Defects, Congenital | 1 | 1999 | 4698 | 0.010 |
Why?
|
Prospective Studies | 3 | 2004 | 54798 | 0.010 |
Why?
|
Fluorescent Antibody Technique | 1 | 2006 | 2470 | 0.010 |
Why?
|
Muscle, Smooth | 2 | 2000 | 931 | 0.010 |
Why?
|
Mucins | 1 | 2005 | 568 | 0.010 |
Why?
|
Cysteine Endopeptidases | 1 | 2004 | 542 | 0.010 |
Why?
|
Information Dissemination | 1 | 2009 | 1140 | 0.010 |
Why?
|
Drug Administration Schedule | 1 | 1989 | 4849 | 0.010 |
Why?
|
Arterial Occlusive Diseases | 1 | 1985 | 758 | 0.010 |
Why?
|
Multienzyme Complexes | 1 | 2004 | 663 | 0.010 |
Why?
|
8-Bromo Cyclic Adenosine Monophosphate | 1 | 2000 | 72 | 0.010 |
Why?
|
Autoradiography | 1 | 2001 | 723 | 0.010 |
Why?
|
Stroke Volume | 3 | 1989 | 5594 | 0.010 |
Why?
|
Electrophoresis, Polyacrylamide Gel | 1 | 2003 | 1724 | 0.010 |
Why?
|
Mice, Nude | 2 | 1997 | 3612 | 0.010 |
Why?
|
Perfusion | 1 | 1985 | 1408 | 0.010 |
Why?
|
Microscopy, Confocal | 1 | 2006 | 1965 | 0.010 |
Why?
|
Nitrogen Oxides | 1 | 2000 | 128 | 0.010 |
Why?
|
Nitric Oxide Donors | 1 | 2000 | 122 | 0.010 |
Why?
|
Behavior, Addictive | 1 | 2005 | 423 | 0.010 |
Why?
|
Adenocarcinoma | 2 | 1994 | 6360 | 0.010 |
Why?
|
Psoriasis | 1 | 2007 | 919 | 0.010 |
Why?
|
Microscopy, Fluorescence | 1 | 2006 | 2626 | 0.010 |
Why?
|
Interdisciplinary Communication | 1 | 2005 | 931 | 0.010 |
Why?
|
Animals, Newborn | 1 | 2005 | 2670 | 0.010 |
Why?
|
Solubility | 1 | 2001 | 1078 | 0.010 |
Why?
|
Guanylate Cyclase | 1 | 2000 | 205 | 0.010 |
Why?
|
Radionuclide Imaging | 1 | 2003 | 1984 | 0.010 |
Why?
|
Microspheres | 1 | 2002 | 773 | 0.010 |
Why?
|
Fibrinolysis | 1 | 2000 | 331 | 0.010 |
Why?
|
Jugular Veins | 1 | 2000 | 211 | 0.010 |
Why?
|
Hydrazines | 1 | 2000 | 223 | 0.010 |
Why?
|
Protein Kinase Inhibitors | 1 | 2014 | 5692 | 0.010 |
Why?
|
Fluorescent Dyes | 1 | 2006 | 1929 | 0.010 |
Why?
|
Nucleocapsid Proteins | 1 | 1998 | 75 | 0.010 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2001 | 1678 | 0.010 |
Why?
|
Transplantation, Isogeneic | 1 | 1997 | 250 | 0.010 |
Why?
|
Central Nervous System | 1 | 1985 | 1342 | 0.010 |
Why?
|
Proteasome Endopeptidase Complex | 1 | 2004 | 1313 | 0.010 |
Why?
|
L-Selectin | 1 | 1998 | 212 | 0.010 |
Why?
|
Emergency Medical Services | 1 | 1989 | 1936 | 0.010 |
Why?
|
Neutrophil Activation | 1 | 1998 | 179 | 0.010 |
Why?
|
Fibrin | 1 | 2000 | 514 | 0.010 |
Why?
|
Nitric Oxide Synthase | 1 | 2000 | 911 | 0.010 |
Why?
|
Ultrasonography | 1 | 1990 | 5995 | 0.010 |
Why?
|
Nitric Oxide Synthase Type III | 1 | 2000 | 707 | 0.010 |
Why?
|
Eye | 1 | 2001 | 710 | 0.010 |
Why?
|
Genes, Viral | 1 | 1998 | 654 | 0.010 |
Why?
|
Virulence | 1 | 2000 | 1287 | 0.010 |
Why?
|
Permeability | 1 | 1998 | 726 | 0.010 |
Why?
|
Leiomyosarcoma | 1 | 2000 | 425 | 0.010 |
Why?
|
Guinea Pigs | 1 | 1998 | 1300 | 0.010 |
Why?
|
Poverty | 1 | 2007 | 2714 | 0.010 |
Why?
|
NF-kappa B p52 Subunit | 1 | 1994 | 35 | 0.010 |
Why?
|
Injections, Intralesional | 1 | 1995 | 281 | 0.010 |
Why?
|
Heart Failure | 2 | 1990 | 11838 | 0.010 |
Why?
|
Receptors, IgG | 1 | 1998 | 559 | 0.010 |
Why?
|
Sex Factors | 2 | 2004 | 10607 | 0.010 |
Why?
|
Amino Acid Sequence | 1 | 2006 | 13402 | 0.010 |
Why?
|
Skin Neoplasms | 1 | 1993 | 5837 | 0.010 |
Why?
|
Clinical Trials, Phase I as Topic | 1 | 1995 | 330 | 0.010 |
Why?
|
Ligands | 1 | 2001 | 3273 | 0.010 |
Why?
|
Prevalence | 1 | 2011 | 15832 | 0.010 |
Why?
|
Heart Transplantation | 1 | 1988 | 3310 | 0.010 |
Why?
|
Neoplasm Transplantation | 1 | 1997 | 2011 | 0.010 |
Why?
|
Isoenzymes | 1 | 1998 | 1688 | 0.010 |
Why?
|
Analysis of Variance | 1 | 2002 | 6204 | 0.010 |
Why?
|
Granulocyte-Macrophage Colony-Stimulating Factor | 1 | 1996 | 890 | 0.010 |
Why?
|
Antibody Formation | 1 | 1998 | 1391 | 0.010 |
Why?
|
beta 2-Microglobulin | 1 | 1994 | 330 | 0.010 |
Why?
|
Genetic Heterogeneity | 1 | 1996 | 735 | 0.010 |
Why?
|
Stress, Psychological | 1 | 1988 | 4528 | 0.010 |
Why?
|
Prenatal Exposure Delayed Effects | 1 | 2005 | 2532 | 0.010 |
Why?
|
Mice, SCID | 1 | 1997 | 2627 | 0.010 |
Why?
|
Exercise | 1 | 1989 | 5937 | 0.010 |
Why?
|
Infusions, Parenteral | 1 | 1992 | 395 | 0.010 |
Why?
|
Statistics as Topic | 2 | 1989 | 2350 | 0.010 |
Why?
|
Adolescent | 3 | 2010 | 88794 | 0.010 |
Why?
|
Attention Deficit Disorder with Hyperactivity | 1 | 2007 | 3718 | 0.010 |
Why?
|
Proto-Oncogene Proteins p21(ras) | 1 | 2000 | 1764 | 0.010 |
Why?
|
Smoking | 1 | 1989 | 9081 | 0.010 |
Why?
|
Immune Tolerance | 1 | 2001 | 2324 | 0.010 |
Why?
|
Aged, 80 and over | 4 | 1990 | 59506 | 0.010 |
Why?
|
Infant, Newborn | 1 | 2011 | 26337 | 0.010 |
Why?
|
Hemophilia B | 1 | 1991 | 83 | 0.010 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 1 | 1993 | 694 | 0.010 |
Why?
|
Diagnostic Imaging | 1 | 2005 | 3527 | 0.010 |
Why?
|
Blotting, Southern | 1 | 1991 | 772 | 0.010 |
Why?
|
Cell Separation | 1 | 1996 | 1718 | 0.010 |
Why?
|
Child | 2 | 2010 | 80509 | 0.010 |
Why?
|
Bipolar Disorder | 1 | 2007 | 5127 | 0.010 |
Why?
|
Iloprost | 1 | 1989 | 25 | 0.010 |
Why?
|
Lung Neoplasms | 1 | 1994 | 13446 | 0.010 |
Why?
|
Blotting, Northern | 1 | 1991 | 1545 | 0.010 |
Why?
|
Splanchnic Circulation | 1 | 1990 | 122 | 0.010 |
Why?
|
Renal Circulation | 1 | 1990 | 290 | 0.010 |
Why?
|
Phenylephrine | 1 | 1990 | 291 | 0.010 |
Why?
|
Blood Platelets | 1 | 2000 | 2464 | 0.010 |
Why?
|
Cloning, Molecular | 1 | 1994 | 4165 | 0.010 |
Why?
|
Epithelium | 1 | 1993 | 1602 | 0.000 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 1995 | 8601 | 0.000 |
Why?
|
Mutagenesis, Insertional | 1 | 1991 | 661 | 0.000 |
Why?
|
Interferon-gamma | 1 | 1996 | 3160 | 0.000 |
Why?
|
Catecholamines | 1 | 1989 | 385 | 0.000 |
Why?
|
Clinical Protocols | 1 | 1994 | 1438 | 0.000 |
Why?
|
Myocardial Reperfusion | 1 | 1989 | 338 | 0.000 |
Why?
|
Forearm | 1 | 1990 | 426 | 0.000 |
Why?
|
Case-Control Studies | 1 | 2005 | 22227 | 0.000 |
Why?
|
Enhancer Elements, Genetic | 1 | 1993 | 1365 | 0.000 |
Why?
|
Angiocardiography | 1 | 1986 | 149 | 0.000 |
Why?
|
HIV | 1 | 1993 | 1585 | 0.000 |
Why?
|
Self Administration | 1 | 1987 | 386 | 0.000 |
Why?
|
Vascular Patency | 1 | 1989 | 924 | 0.000 |
Why?
|
Thorax | 1 | 1989 | 553 | 0.000 |
Why?
|
Infant | 1 | 2008 | 36375 | 0.000 |
Why?
|
Glucocorticoids | 1 | 1995 | 2132 | 0.000 |
Why?
|
Glioma | 1 | 2000 | 3493 | 0.000 |
Why?
|
Child, Preschool | 1 | 2008 | 42478 | 0.000 |
Why?
|
False Positive Reactions | 1 | 1986 | 957 | 0.000 |
Why?
|
Shock, Cardiogenic | 1 | 1989 | 707 | 0.000 |
Why?
|
Chromosome Mapping | 1 | 1991 | 4618 | 0.000 |
Why?
|
Hypotension | 1 | 1988 | 883 | 0.000 |
Why?
|
Heart Atria | 1 | 1988 | 1363 | 0.000 |
Why?
|
Neoplasm Staging | 1 | 1996 | 11205 | 0.000 |
Why?
|
Epithelial Cells | 1 | 1993 | 3682 | 0.000 |
Why?
|
Cytokines | 1 | 1994 | 7425 | 0.000 |
Why?
|
Transplantation, Homologous | 1 | 1988 | 4858 | 0.000 |
Why?
|
Cause of Death | 1 | 1989 | 3710 | 0.000 |
Why?
|
Magnetic Resonance Imaging | 1 | 2003 | 36542 | 0.000 |
Why?
|
Pain | 1 | 1989 | 5076 | 0.000 |
Why?
|
Transcription Factors | 1 | 1993 | 12122 | 0.000 |
Why?
|
Hospitalization | 1 | 1989 | 10803 | 0.000 |
Why?
|
Follow-Up Studies | 1 | 1989 | 39226 | 0.000 |
Why?
|